1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow ShengFa Su: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer irinotecan plus lobaplatin, irinotecan - Small-cell Lung Cancer | Phase 2 | Unknown | ShengFa Su | 72 | 2018-06-01 | 2020-02-05 |
Recurrence (1) · Small Cell Lung Carcinoma (1)
Irinotecan (1) · lobaplatin (1)
China (1)